Cathepsin D Stably Over-expressing SH-SY5Y Cell Line

Unit

1×10⁶ cells / 1.0 ml

Cell Type

Stable (KO/Expressing) Cells

Tissue Type

Nerve

Organism

Human (H. sapiens)

Donor History

Female

,

4

,

Neuroblastoma

Growth Properties

Adherent

,

epithelial

Growth Conditions

PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture. 1:1 mixture of Prigrow VIII Medium (TM018) and PriGrow XVII Medium (TM029) + 10% FBS + 1% L-Glutamine (G275) + 1% Penicillin/Streptomycin Solution (G255)

,

37.0°C

,

5% CO₂.Note: Cells are sensitive to trypsin; Gentle Dissociation Solution (TM080) is recommended for subculture procedures. 

Immortalization Method
Full Information
Katalogové číslo: T3528 Kategorie: ,
Popis

This cell line was developed using the Tet-On gene expression system to enable tetracycline-inducible overexpression of Cathepsin D (CD). The human neuroblastoma SH-SY5Y cells were initially transfected with the pcDNA6/TR© vector and subsequently with vectors containing Cathepsin D cDNA. Stable expression was achieved by selecting with blasticidin, followed by induction with tetracycline. Cells express high levels of enzymatically active Cathepsin D when induced, which is shown to reduce the proliferative potential of the cells, possibly through downregulation of the pro-oncogenic MAPK signaling pathway. Ideal for studying the anti-proliferative effects of Cathepsin D in neuroblastoma, the interaction with EGFR signaling, and exploring new therapeutic approaches involving the manipulation of lysosomal enzymes.Additional cell lines from this panel: T3529 – Cathepsin D Stable Knockout SH-SY5Y Cell Line

O značce
Applied Biological Materials (abm) je jedním z našich klíčových dodavatelů pro biotechnologický průmysl. Společnost byla založena v roce 2004 a již více než deset let podporuje vědecké objevy v oblasti přírodních věd a vývoje léčiv. Její sídlo se nachází ve Vancouveru v Kanadě. ABM je pro nás neocenitelným partnerem zejména v  oblasti dodávek buněčných kultur, genových a virových vektorů, produktů pro molekulární biologii a PCR, nástrojů pro technologie CRISPR a RNAi, protilátek i základních reagencií pro molekulárně genetické procesy.